title: Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.
abstract: Tardive dyskinesia (TD) is a disfiguring side-effect of antipsychotic medications that is potentially irreversible in affected patients. Newer atypical antipsychotics are felt by many to have a lower risk of TD. As a result, many clinicians may have developed a false sense of security when prescribing these medications. We report five cases of patients taking atypical antipsychotics who developed TD, review the risk of TD, its potential etiologic mechanisms, and treatment options available. The goal of this paper is to alert the reader to continue to be diligent in obtaining informed consent and monitoring for the onset of TD in patients taking atypical antipsychotics.
authors.affiliation: SUNY Upstate Medical University, Department of Psychiatry, Syracuse, New York, USA.
authors.forename: Jungjin
authors.initials: J
authors.lastname: Kim
authors.affiliation: SUNY Upstate Medical University, Department of Psychiatry, Syracuse, New York, USA.
authors.forename: Eric
authors.initials: E
authors.lastname: Macmaster
authors.affiliation: SUNY Upstate Medical University, Department of Psychiatry, Syracuse, New York, USA.
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Schwartz
keywords: antipsychotic agents; dopamine receptor antagonists; tardive dyskinesia (TD)
references.citation: Am J Med Genet. 2001 Aug 8;105(6):498-501
references.pmid: 11496364
references.citation: CNS Spectr. 2006 Jun;11(6):435-9
references.pmid: 16816781
references.citation: Tremor Other Hyperkinet Mov (N Y). 2013 Jul 12;3:
references.pmid: 23858394
references.citation: J Clin Psychiatry. 1996 Apr;57(4):167-73
references.pmid: 8601552
references.citation: Am J Psychiatry. 2004 Mar;161(3):414-25
references.pmid: 14992963
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):1135-6
references.pmid: 20460141
references.citation: J Clin Psychiatry. 2010 Apr;71(4):463-74
references.pmid: 20156410
references.citation: Am J Psychiatry. 1990 Apr;147(4):445-51
references.pmid: 1969244
references.citation: Clin Neuropharmacol. 2006 Sep-Oct;29(5):265-8
references.pmid: 16960471
references.citation: Dis Nerv Syst. 1977 Jun;38(6):423-7
references.pmid: 16734
references.citation: Clin Schizophr Relat Psychoses. 2010 Apr;4(1):56-73
references.pmid: 20643630
references.citation: Int J Neuropsychopharmacol. 2005 Sep;8(3):411-25
references.pmid: 15857569
references.citation: Arch Gen Psychiatry. 1989 Oct;46(10):908-13
references.pmid: 2572205
references.citation: Neurology. 2013 Jul 30;81(5):463-9
references.pmid: 23897874
references.citation: Biol Psychiatry. 1993 May 15;33(10):700-6
references.pmid: 8102552
references.citation: Mol Psychiatry. 1998 Mar;3(2):123-34
references.pmid: 9577836
references.citation: Biol Psychiatry. 1997 Apr 1;41(7):827-9
references.pmid: 9084902
references.citation: Ann Neurol. 1992 Apr;31(4):366-73
references.pmid: 1350190
references.citation: Clin Neuropharmacol. 1983 Jun;6(2):91-9
references.pmid: 6133621
references.citation: Curr Treat Options Neurol. 2000 May;2(3):205-214
references.pmid: 11096748
references.citation: Arch Gen Psychiatry. 1982 Apr;39(4):473-81
references.pmid: 6121548
references.citation: J Clin Psychiatry. 2004 Jan;65(1):92-6
references.pmid: 14744176
references.citation: Am J Psychiatry. 1973 Apr;130(4):479-83
references.pmid: 4570750
references.citation: Mov Disord. 2004 Aug;19(8):969-72
references.pmid: 15300668
references.citation: J Clin Psychiatry. 1995 Apr;56(4):173
references.pmid: 7713860
references.citation: Psychiatr Genet. 2003 Sep;13(3):187-92
references.pmid: 12960753
references.citation: Eur J Pharmacol. 1991 Jun 19;207(2):165-8
references.pmid: 1679015
references.citation: Mol Psychiatry. 2008 May;13(5):544-56
references.pmid: 18180754
references.citation: Am J Psychiatry. 2003 Jun;160(6):1117-24
references.pmid: 12777270
references.citation: Cochrane Database Syst Rev. 2006 Jul 19;(3):CD000205
references.pmid: 16855954
references.citation: Clin Ther. 2012 Jul;34(7):1487-504
references.pmid: 22749259
references.citation: Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000203
references.pmid: 15494993
references.citation: Schizophr Bull. 1992;18(4):701-15
references.pmid: 1359633
references.citation: J Clin Psychiatry. 2011 May;72(5):615-21
references.pmid: 20868638
references.citation: Prog Neurobiol. 2000 Aug;61(5):525-41
references.pmid: 10748322
references.citation: Acta Psychiatr Scand. 1988 Apr;77(4):369-78
references.pmid: 2898870
references.citation: Mov Disord. 2006 Aug;21(8):1219-21
references.pmid: 16637037
references.citation: J Clin Psychiatry. 2008 Oct;69(10):1580-8
references.pmid: 19192441
references.citation: Clin Neuropharmacol. 1991 Dec;14(6):562-5
references.pmid: 1837757
references.citation: CNS Drugs. 2003;17(1):47-62
references.pmid: 12467492
references.citation: Arch Gen Psychiatry. 2007 Feb;64(2):170-6
references.pmid: 17283284
references.citation: Am J Psychiatry. 2005 Oct;162(10):1984-5
references.pmid: 16199855
references.citation: J Clin Psychiatry. 2005 Jan;66(1):107-10
references.pmid: 15669896
references.citation: J Pharmacol Exp Ther. 2004 Aug;310(2):687-94
references.pmid: 15044557
references.citation: Prim Care Companion J Clin Psychiatry. 2010;12(2):
references.pmid: 20694120
references.citation: Neuron. 2010 Aug 12;67(3):466-79
references.pmid: 20696383
references.citation: Am J Psychiatry. 1999 Aug;156(8):1279-81
references.pmid: 10450276
references.citation: Psychopharmacol Bull. 1986;22(1):254-8
references.pmid: 2873613
references.citation: Rev Neurol (Paris). 1959 Jun;100:751-5
references.pmid: 14446619
references.citation: J Clin Psychiatry. 2012 Nov;73(11):1434-8
references.pmid: 23218160
references.citation: Arch Gen Psychiatry. 1999 Sep;56(9):836-41
references.pmid: 12892048
references.citation: Pharmacogenet Genomics. 2005 Mar;15(3):151-8
references.pmid: 15861039
references.citation: Mol Psychiatry. 2000 Jul;5(4):410-7
references.pmid: 10889552
references.citation: Mov Disord. 2010 Jun 15;25(8):1068-76
references.pmid: 20222137
references.citation: J Neural Transm. 1972;33(3):235-46
references.pmid: 4674512
references.citation: Neurology. 2003 Aug 12;61(3):419
references.pmid: 12913217
references.citation: J Clin Psychopharmacol. 2009 Feb;29(1):5-8
references.pmid: 19142099
references.citation: Mov Disord. 2013 Oct;28(12):1748-9
references.pmid: 23637028
references.citation: Int Clin Psychopharmacol. 2005 Jul;20(4):183-98
references.pmid: 15933479
references.citation: Ann N Y Acad Sci. 1989;570:176-85
references.pmid: 2576510
references.citation: Brain Res Mol Brain Res. 1994 Jul;24(1-4):199-209
references.pmid: 7968358
references.citation: Parkinsonism Relat Disord. 2013 Feb;19(2):141-7
references.pmid: 23099106
references.citation: Nature. 1984 May 24-30;309(5966):347-9
references.pmid: 6727989
references.citation: Neurology. 1988 Mar;38(3):391-4
references.pmid: 3279337
references.citation: J Clin Psychopharmacol. 1997 Apr;17(2):88-91
references.pmid: 10950469
references.citation: Psychopharmacology (Berl). 1999 Apr;143(4):358-64
references.pmid: 10367552
references.citation: Biol Psychiatry. 1982 Jun;17(6):719-27
references.pmid: 6179548
references.citation: J Neurosci. 2005 Apr 13;25(15):3857-69
references.pmid: 15829638
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2004 Nov;28(7):1099-107
references.pmid: 15610922
references.citation: J Neurol Sci. 1971 Oct;14(2):189-92
references.pmid: 5112211
references.citation: Hosp Community Psychiatry. 1990 Nov;41(11):1203-11
references.pmid: 1979044
references.citation: Exp Neurol. 1995 Jun;133(2):175-88
references.pmid: 7544289
references.citation: Psychol Med. 1980 Feb;10(1):55-72
references.pmid: 6104342
references.citation: N Engl J Med. 1971 Oct 7;285(15):860
references.pmid: 5570853
references.citation: Neuropsychopharmacology. 2002 Jul;27(1):105-19
references.pmid: 12062911
references.citation: Psychiatry Res. 1995 Aug 8;61(2):95-102
references.pmid: 7480392
references.citation: Acta Neurol Scand. 2009 Apr;119(4):269-73
references.pmid: 18976318
references.citation: Am J Psychiatry. 2007 Sep;164(9):1436-7
references.pmid: 17728431
references.citation: J Neurosci. 2011 Nov 2;31(44):15727-31
references.pmid: 22049415
references.citation: J Clin Psychopharmacol. 1993 Jun;13(3):204-9
references.pmid: 8102622
references.citation: Cochrane Database Syst Rev. 2001;(4):CD000209
references.pmid: 11687073
references.citation: Brain Res Bull. 2004 Dec 15;64(4):339-45
references.pmid: 15561469
references.citation: J Psychopharmacol. 2012 Sep;26(9):1167-74
references.pmid: 22651987
references.citation: Psychopharmacology (Berl). 1981;73(4):359-62
references.pmid: 6789358
references.citation: Psychopharmacology (Berl). 1997 May;131(2):174-9
references.pmid: 9201806
references.citation: Arch Gen Psychiatry. 1995 Mar;52(3):173-88
references.pmid: 7872841
references.citation: Curr Opin Psychiatry. 2008 Mar;21(2):151-6
references.pmid: 18332662
references.citation: Arch Gen Psychiatry. 1980 Dec;37(12):1368-73
references.pmid: 6108750
references.citation: J Clin Psychiatry. 2001 Feb;62(2):128-9
references.pmid: 11247101
references.citation: Mov Disord. 2012 Sep 1;27(10):1205-15
references.pmid: 22865512
references.citation: Arch Gen Psychiatry. 2003 Oct;60(10):974-7
references.pmid: 14557141
references.citation: J Clin Psychiatry. 2008 Apr;69(4):546-54
references.pmid: 18312060
references.citation: Clin Neuropharmacol. 2010 Nov-Dec;33(6):271-5
references.pmid: 21121175
references.citation: Eur Neuropsychopharmacol. 2010 Feb;20(2):132-6
references.pmid: 19740630
references.citation: Psychopharmacology (Berl). 2003 Jan;165(2):166-71
references.pmid: 12417967
references.citation: P T. 2008 Jan;33(1):32-4
references.pmid: 19749988
references.citation: Arch Gen Psychiatry. 1987 Jun;44(6):522-9
references.pmid: 3034188